CRANBURY, N.J., May 30 /PRNewswire/ -- Innophos Holdings, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed underwritten secondary offering of its common stock. The proposed offering will include shares sold by certain of Innophos’ stockholders. Innophos will not receive any of the proceeds from this offering.
5,000,000 shares are proposed to be offered at a price range that will be based upon prevailing market prices. The underwriters will also have an option to purchase an additional 750,000 shares of common stock from the selling stockholders to cover over-allotments, if any. The offering will be made only by means of a prospectus.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any State or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State or jurisdiction.
Safe Harbor for Forward-Looking and Cautionary Statements
This press release and the documents referred to herein contain forward- looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos’ products and services in the marketplace; competitive factors; technological changes; Innophos’ dependence upon third- party suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.
About Innophos Holdings, Inc.
Innophos Holdings, Inc. (www.innophos.com), the holding company for a leading North American manufacturer of specialty phosphates, serves a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos’ market-leading positions derive from its experience and dedication to customer service and innovation. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and Mission Hills, Guanajuato (Mexico). ‘IPHS-G’
Innophos Holdings, Inc.
CONTACT: Innophos Investor Relations, +1-609-366-1299,Investor.relations@innophos.com, Public Relations, Alex Stanton of StantonCrenshaw Communications, +1-212-780-1900, alex@stantoncrenshaw.com
Web site: http://www.innophos.com//
